I think the share price is saying that it could be a soft half year as far as revenue goes compared to the full year guidance of $11 to $18 million. We shall see.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025